Loss of Hippo kinase LATS2 preserves beta cell survival and function in diabetes

被引：0
|
作者：
Annamalai, K. [1 ]
Yuan, T. [1 ]
Lupse, B. [1 ]
Lim, D. [2 ]
Maedler, K. [1 ]
Ardestani, A. [1 ]
机构：
[1] Ctr Biomol Interact Bremen, Islet Cell Biol, Bremen, Germany
[2] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea
来源：
DIABETOLOGIA | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
65
引用
收藏
页码：S34 / S35
页数：2
相关论文
共 50 条
  • [11] Lats2 Modulates Adipocyte Proliferation and Differentiation via Hippo Signaling
    An, Yang
    Kang, Qianqian
    Zhao, Yaofeng
    Hu, Xiaoxiang
    Li, Ning
    PLOS ONE, 2013, 8 (08):
  • [12] WBP2 promotes gastric cancer cell migration via novel targeting of LATS2 kinase in the Hippo tumor suppressor pathway
    Hum, Melissa
    Tan, Hock Jin
    Yang, Yixuan
    Srivastava, Supriya
    Teh, Ming
    Lim, Yoon Pin
    FASEB JOURNAL, 2021, 35 (02):
  • [13] Novel insights into the regulation of LATS2 kinase in prehierarchical follicle development via the Hippo pathway in hen ovary
    Sun, Xue
    Niu, Xiaotian
    Qin, Ning
    Shan, Xuesong
    Zhao, Jinghua
    Ma, Chang
    Xu, Rifu
    Mishra, Birendra
    POULTRY SCIENCE, 2021, 100 (12)
  • [14] Development of selective LATS1/LATS2 inhibitors for the pharmacologic modulation of the Hippo signaling pathway.
    Ceribelli, Michele
    Morris, Patrick
    Duveau, Damien
    Tosto, Frances A.
    Hoyt, Scott
    Thomas, Craig J.
    MOLECULAR CANCER RESEARCH, 2020, 18 (08) : 45 - 45
  • [15] The Hippo pathway kinase Lats2 prevents DNA damage-induced apoptosis through inhibition of the tyrosine kinase c-Abl
    Reuven, N.
    Adler, J.
    Meltser, V.
    Shaul, Y.
    CELL DEATH AND DIFFERENTIATION, 2013, 20 (10): : 1330 - 1340
  • [16] Kpm/Lats2 of the Hippo Pathway Is Linked to Chemo-Sensitivity of Leukemic Cells
    Kawahara, Masahiro
    Hori, Toshiyuki
    Chonabayashi, Kazuhisa
    Oka, Tsutomu
    Sudol, Marius
    Uchiyama, Takashi
    BLOOD, 2008, 112 (11) : 635 - 635
  • [17] The Hippo pathway kinase Lats2 prevents DNA damage-induced apoptosis through inhibition of the tyrosine kinase c-Abl
    N Reuven
    J Adler
    V Meltser
    Y Shaul
    Cell Death & Differentiation, 2013, 20 : 1330 - 1340
  • [18] O-GlcNAcylation on LATS2 disrupts the Hippo pathway by inhibiting its activity
    Kim, Eunah
    Kang, Jeong Gu
    Kang, Min Jueng
    Park, Jae Hyung
    Kim, Yeon Jung
    Kweon, Tae Hyun
    Lee, Han-Woong
    Jho, Eek-hoon
    Lee, Yong-ho
    Kim, Seung-Il
    Yi, Eugene C.
    Park, Hyun Woo
    Yang, Won Ho
    Cho, Jin Won
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (25) : 14259 - 14269
  • [19] Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway
    Zhu, Chu
    Ji, Xinyan
    Zhang, Haitao
    Zhou, Qi
    Cao, Xiaolei
    Tang, Mei
    Si, Yuan
    Yan, Huan
    Li, Li
    Liang, Tingbo
    Feng, Xin-Hua
    Zhao, Bin
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (04) : 1178 - 1191
  • [20] A kinase shRNA screen links LATS2 and the pRB tumor suppressor
    Tschoep, Katrin
    Conery, Andrew R.
    Litovchick, Larisa
    DeCaprio, James A.
    Settleman, Jeffrey
    Harlow, Ed
    Dyson, Nicholas
    GENES & DEVELOPMENT, 2011, 25 (08) : 814 - 830
12345